Vascular Surgery

Paolo Valle is the Professional of Phlebology at Unit of General Surgery.

Vascular Surgery

Wanfen Xiong is an Associate Professor at the University of Nebraska Medical Centre. She received her Ph.D. in Biochemistry and Molecular Biology. Since she completed her post-Doctoral training at Stanford University in 1999, she has worked to understand Etiology and mechanism of Aortic aneurysms. Though the study of Murine Marfan Syndrome (MFS) model, she has shown that smooth muscle cells (SMCs) switched prematurely to a more mature contractile phenotype at postnatal day 7 in MFS mice. Her research interests are to understand the molecular mechanisms underlying early aneurysm development in Marfan syndrome and develop effective strategies to prevent Aneurysm formation.

Aortic aneurysms

Senior consultant at Elbe-Elster Klinikum, Germany

Vascular Surgery

Patrick Kelly, MD, practices vascular surgery, and is a board-certified and fellowship-trained surgeon. He is an active inventor of medical devices with over two dozen issued or pending patents and several approved, physician-sponsored clinical trials.

Vascular Surgery

Ihor Huk is an International Member of Ukrainian Academy of Science. He has participated in scientific meetings of Medical University of Vienna and given some lectures.His interest was always with regards to biochemistry and pathophysiology of humans cells. In Vienna, he became one of the famous surgeons, as his rector mentioned it recently, by doing thousands of organ transplantations and vascular procedures. From his experimental laboratory Medi-cal University of Vienna many exciting papers were published in top journals e.g. Circulation, Stroke, EJVES, JVS etc. His fundamental work was published in Circulation trying to explain how endothelial nitric oxide synthase can derange and in spite of nitric oxide is going to synthetize oxygen radical-superoxide. This paper is a classical citation paper on the patho-physiology of endothelium.

Vascular surgery

Dr. Ulf Thorsten Zierau is the Founder and CEO of Saphenion, Germany. He is one of the first vascular surgeons who were allowed to work in the artery system using catheter technology.Although he is a surgeon and vascular surgeon with a passion consistently with the gentlest treatment methods work when it comes to removing spider veins and varicose veins. This led to an all-changing decision in 2012 - no more radical surgery on the venous system! No stripping and no phlebectomy (checkmark method). His Researches mostly focus on Vascular Surgery, Endovascular specialist artery, Endovenous Surgery, phlebology.

Vascular and Endovascular Surgery